VRNA

Verona Pharma
VRNA

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$5.38B
EV
$5.21B
Shares Outstanding
88.11M
Beta
0.16

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$80.89
P/E 2025E
-
P/Revenue 2025E
16.63x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Verona Pharma plc

gainify
VRNA

Verona Pharma plc

VRNA

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company’s product candidate is ensifentrine, an inhaled and dual inhibitor ...

Sector

Healthcare

Industry

Biotechnology

CEO

Zaccardelli, David

Employees

209

IPO Date

2017-04-28

Headquarters

3 More London Riverside, London, Greater London, SE1 2RE, United Kingdom

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved